{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:21Z","timestamp":1760145981901,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["#82260360","#20222C264164","#2022AC18004","#2022AC21040"],"award-info":[{"award-number":["#82260360","#20222C264164","#2022AC18004","#2022AC21040"]}]},{"name":"Guilin Innovation Platform and Talent Program","award":["#82260360","#20222C264164","#2022AC18004","#2022AC21040"],"award-info":[{"award-number":["#82260360","#20222C264164","#2022AC18004","#2022AC21040"]}]},{"name":"Guangxi Science and Technology Base and Talent Project","award":["#82260360","#20222C264164","#2022AC18004","#2022AC21040"],"award-info":[{"award-number":["#82260360","#20222C264164","#2022AC18004","#2022AC21040"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Prostate cancer (PCa) management commonly involves the utilization of prostate radiotherapy (PRT), pelvic nodal radiotherapy (PNRT), and androgen deprivation therapy (ADT). However, the potential association of these treatment modalities with bone marrow (BM) suppression remains inadequately reported in the existing literature. This study is designed to comprehensively evaluate the risk of myelosuppression associated with PRT, shedding light on an aspect that has been underrepresented in prior research. Materials and Methods: We conducted a retrospective analysis of 600 patients with prostate cancer (PCa) treated with prostate radiotherapy (PRT) at a single oncology center between 2007 and 2017. Patients were categorized into four cohorts: PRT alone (n = 149), PRT + ADT, (n = 91), PRT + PNRT (n = 39), and PRT + PNRT + ADT (n = 321). To assess the risk of myelosuppression, we scrutinized specific blood parameters, such as hemoglobin (HGB), white blood cells (WBCs), neutrophils (NEUT), lymphocytes (LYM), and platelets (PLT) at baseline, mid-treatment (mRT), immediately post-RT (pRT), 1 month post-RT (1M-pRT), and 1 year post-RT (1Y-pRT). The inter-cohort statistical significance was evaluated with further stratification based on the utilized RT technique {3D conformal radiotherapy (3D-CRT), and intensity-modulated radiation therapy (IMRT)}. Results: Significant statistical differences at baseline were observed in HGB and LYM values among all cohorts (p &lt; 0.05). Patients in the PRT + PNRT + ADT cohort had significantly lower HGB at baseline and 1M-pRT. In patients undergoing ADT, BMS had a significant impact at 1M-pRT {odds ratio (OR) 9.1; 95% Confidence Interval (CI) 4.8\u201317.1} and at 1Y-pRT (OR 2.84; CI 1.14\u20137.08). The use of 3D-CRT was linked to reduced HGB levels in the PRT + PNRT + ADT group at 1 month pRT (p = 0.015). Similarly, PNRT significantly impacted BMS at 1M-pRT (OR 6.7; CI 2.6\u201317.2). PNRT increased the odds of decreased WBC counts at 1Y-pRT (OR 6.83; CI: 1.02\u201345.82). Treatment with any RT techniques (3D-CRT or IMRT), particularly in the PRT + PNRT and PRT + PNRT + ADT groups, significantly increased the odds of low LYM counts at all time points except immediately pRT (p &lt; 0.05). Furthermore, NEUT counts were considerably lower at 1M-pRT (p &lt; 0.05) in the PRT + PNRT + ADT group. PLT counts were significantly decreased by PRT + PNRT + ADT at mRT (OR 2.57; 95% CI: 1.42\u20134.66) but were not significantly impacted by the RT technique. Conclusions: Treatment with PRT, ADT, PNRT, and 3D-CRT is associated with BMS. Despite this statistically significant risk, no patient required additional interventions to manage the outcome. While its clinical impact appears limited, its importance cannot be underestimated in the context of increased integration of novel systemic agents with myelosuppressive properties. Longer follow-up should be considered in future studies.<\/jats:p>","DOI":"10.3390\/curroncol31090402","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T08:45:53Z","timestamp":1726217153000},"page":"5439-5451","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Effects of Prostate Radiotherapy Intensified with Pelvic Nodal Radiotherapy and Androgen Deprivation Therapy on Myelosuppression: Single-Institution Experience"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7894-2490","authenticated-orcid":false,"given":"Yousef","family":"Katib","sequence":"first","affiliation":[{"name":"College of Medicine, Taibah University, Madinah 42353, Saudi Arabia"},{"name":"Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H3A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Tisseverasinghe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H3A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-6075","authenticated-orcid":false,"given":"Ian J.","family":"Gerard","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H3A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Royal-Preyra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, McGill University Health Centre, Montreal, QC H3A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3402-9576","authenticated-orcid":false,"given":"Ahmad","family":"Chaddad","sequence":"additional","affiliation":[{"name":"School of Artificial Intelligence, Guilin University of Electronic Technology, Guilin 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Sasson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, McGill University, Montreal, QC H3A 0G4, Canada"},{"name":"Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Bahoric","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Roncarolo","sequence":"additional","affiliation":[{"name":"School of Public Health, Universit\u00e9 de Montr\u00e9al, Montreal, QC H3N 1X9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamim","family":"Niazi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"ref_1","unstructured":"Bray, F., Vyas, M., Henderson, A.M., and Leslie, S.W. (2024). Nuclear Medicine Applications in Prostate Cancer. Stat Pearls [Internet], StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/jnci\/djab131","article-title":"Annual report to the nation on the status of cancer, part 1: National cancer statistics","volume":"113","author":"Islami","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rasul, S., and Haug, A.R. (2022). Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer. Cancers, 14.","DOI":"10.3390\/cancers14153768"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7150\/ntno.64141","article-title":"Radiotheranostics\u2014Precision Medicine in Nuclear Medicine and Molecular Imaging","volume":"6","author":"Duan","year":"2022","journal-title":"Nanotheranostics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/annonc\/mdv222","article-title":"Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Parker","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_7","first-page":"62","article-title":"Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study","volume":"35","author":"Erpolat","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1464-410X.1997.00234.x","article-title":"Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade","volume":"79","author":"Strum","year":"1997","journal-title":"Br. J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1442-2042.2012.03001.x","article-title":"Safety and tolerability of intermittent androgen deprivation therapy: A literature review","volume":"19","author":"Gruca","year":"2012","journal-title":"Int. J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2214\/ajr.96.1.183","article-title":"Effect of focal irradiation on human bone marrow","volume":"96","author":"Lehar","year":"1966","journal-title":"Am. J. Roentgenol. Radium. Ther. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.eururo.2014.09.032","article-title":"Survival with newly diagnosed meta- static prostate cancer in the \u201cdocetaxel era\u201d: Data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK\/06\/019)","volume":"67","author":"James","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijrobp.2008.12.039","article-title":"Imaging cellular proliferation during chemo-radiotherapy: A pilot study of serial 18F-FLT positron emission tomography\/computed tomography imaging for non-small-cell lung cancer","volume":"75","author":"Everitt","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1148\/83.6.1084","article-title":"The effects of varying dosages of irradiation upon sternal-marrow regeneration","volume":"83","author":"Sykes","year":"1964","journal-title":"Radiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/1097-0142(196409)17:9<1144::AID-CNCR2820170907>3.0.CO;2-4","article-title":"Long-term effects of therapeutic irradiation upon bone marrow","volume":"17","author":"Sykes","year":"1964","journal-title":"Cancer"},{"key":"ref_16","first-page":"326","article-title":"Effects of radiations on bone marrow","volume":"27","author":"Tubiana","year":"1979","journal-title":"Pathol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/IGC.0000000000000292","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: Comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy","volume":"24","author":"Hui","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2009.11.010","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy","volume":"79","author":"Rose","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1148\/radiology.194.2.7824737","article-title":"Female pelvic bone marrow: Serial MR imaging before, during, and after radiation therapy","volume":"194","author":"Blomlie","year":"1995","journal-title":"Radiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/1097-0142(197809)42:3<1057::AID-CNCR2820420304>3.0.CO;2-P","article-title":"Bone marrow regeneration following large field radiation: Influence of volume, age, dose, and time","volume":"42","author":"Sacks","year":"1978","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-8140(99)00100-0","article-title":"Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer","volume":"55","author":"Zelefsky","year":"2000","journal-title":"Radiother. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14470","article-title":"Intensity-modulated radiotherapy for the treatment of prostate cancer: A systematic review and economic evaluation","volume":"14","author":"Hummel","year":"2010","journal-title":"Health Technol. Assess."},{"key":"ref_24","first-page":"2803","article-title":"Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients","volume":"19","author":"Miszczyk","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2004.03.035","article-title":"IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk","volume":"60","author":"Ahmed","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0360-3016(02)03801-4","article-title":"Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies","volume":"54","author":"Brixey","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1504A","DOI":"10.1016\/j.ijrobp.2008.04.046","article-title":"Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer","volume":"71","author":"Mell","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.29983","article-title":"Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial","volume":"122","author":"Viani","year":"2016","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(98)00534-3","article-title":"Pelvic insufficiency fractures in patients with pelvic irradiation","volume":"44","author":"Moreno","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ygyno.2006.06.038","article-title":"Pelvic bone complications following radiation therapy of gynecologic malignancies: Clinical evaluation of radiation-induced pelvic insufficiency fractures","volume":"103","author":"Ikushima","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2013.08.036","article-title":"Changes in bone mineral density in uterine cervical cancer patients after radiation therapy","volume":"87","author":"Okonogi","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0973-1482.151864","article-title":"A prospective dosimetric and clinical comparison of acute hematological toxicities in three-dimensional conformal radiation therapy and intensity modulated radiation therapy with concurrent chemotherapy in carcinoma cervix","volume":"11","author":"Avinash","year":"2015","journal-title":"J. Cancer Res. Ther."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/9\/402\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:55:49Z","timestamp":1760111749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/9\/402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["curroncol31090402"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31090402","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}